Stay updated on ESMART: Molecular Stratification Clinical Trial
Sign up to get notified when there's something new on the ESMART: Molecular Stratification Clinical Trial page.

Latest updates to the ESMART: Molecular Stratification Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a new publication citation to Publications: Rubio-San-Simon A et al., Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Children with Advanced Malignancies (Arm K of the AcSe-ESMART Trial), Target Oncol. 2026 Mar 16, DOI: 10.1007/s11523-026-01208-1. Revision: v3.5.0.SummaryDifference0.1%

- Check40 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision: v3.4.2 was added; the funding-status notice and the prior revision note (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check76 days agoChange DetectedI implemented a new site notice about the lapse in government funding and the NIH Clinical Center status, including guidance to visit cc.nih.gov and opm.gov. The page also shows Revision: v3.4.1, replacing the prior v3.4.0 tag.SummaryDifference0.2%

- Check83 days agoChange DetectedAdditions: Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, Revision: v3.4.0. Deletions: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to ESMART: Molecular Stratification Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ESMART: Molecular Stratification Clinical Trial page.